|
1
|
Yang Z, Wang Z, Duan Y and Xu S:
Clinicopathological characteristics and prognosis of resected cases
of carcinoid tumors of the lung. Thorac Cancer. 7:633–638. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kosmidis PA: Treatment of carcinoid of the
lung. Curr Opin Oncol. 16:146–149. 2004. View Article : Google Scholar
|
|
3
|
Fink G, Krelbaum T, Yellin A, Bendayan D,
Saute M, Glazer M and Kramer MR: Pulmonary carcinoid: Presentation,
diagnosis, and outcome in 142 cases in Israel and review of 640
cases from the literature. Chest. 119:1647–1651. 2001. View Article : Google Scholar
|
|
4
|
Fraser RS, Muller NL, Colman N and Pare
PD: Fraser and Pare's diagnosis of diseases of the chest.
Neuroendocrine neoplasms. 4th edition. Philadelphia: WB Saunders
Co; pp. 1229–1250. 1999
|
|
5
|
Colby TV, Koss M and Travis WD: Atlas of
tumor pathology. Tumors of the lower respiratory tract. Armed
Forces Institute of Pathology; Washington, DC: 1995
|
|
6
|
Soga J and Yakuwa Y: Bronchopulmonary
carcinoids: An analysis of 1,875 reported cases with special
reference to a comparison between typical carcinoids and atypical
varieties. Ann Thorac Cardiovasc Surg. 5:211–219. 1999.PubMed/NCBI
|
|
7
|
Mark EJ, Quay SC and Dickersin GR:
Papillary carcinoid tumor of the lung. Cancer. 48:316–324. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Travis WD, Linnoila RI, Tsokos MG,
Hitchcock CL, Cutler GB Jr, Nieman L, Chrousos G, Pass H and
Doppman J: Neuroendocrine tumors of the lung with proposed criteria
for large-cell neuroendocrine carcinoma. An ultrastructural,
immunohistochemical, and flow cytometric study of 35 cases. Am J
Surg Pathol. 15:529–553. 1991. View Article : Google Scholar
|
|
9
|
Travis WD, Rush W, Flieder DB, Falk R,
Fleming MV, Gal AA and Koss MN: Survival analysis of 200 pulmonary
neuroendocrine tumors with clarification of criteria for atypical
carcinoid and its separation from typical carcinoid. Am J Surg
Pathol. 22:934–944. 1998. View Article : Google Scholar
|
|
10
|
Miller RR and Müller NL: Neuroendocrine
cell hyperplasia and obliterative bronchiolitis in patients with
peripheral carcinoid tumors. Am J Surg Pathol. 19:653–658. 1995.
View Article : Google Scholar
|
|
11
|
Wang J, Ren S, Liu Y, Guo K, Chen X, Wang
Z and Chen R: Carcinoid tumorlets co-existing with chronic
pulmonary inflammatory processes: Imaging findings and histological
appearances. Med Sci Monit. 26:e9260142020.
|
|
12
|
Huang Y, Yang X, Lu T, Li M, Zhao M, Yang
X, Ma K, Wang S, Zhan C, Liu Y and Wang Q: Assessment of the
prognostic factors in patients with pulmonary carcinoid tumor: A
population-based study. Cancer Med. 7:2434–2441. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Georgakopoulou VE, Zygouris E, Nikokiris
C, Damaskos C, Pierrakou A, Garmpis N, Garmpi A, Sklapani P,
Aravantinou A, Trakas N, et al: Predictive indicators of survival
in patients with surgically resected lung carcinoid tumors at a
Greek medical center. Cureus. 12:e103002020.PubMed/NCBI
|
|
14
|
Georgakopoulou VE, Zygouris E, Damaskos C,
Pierrakou A, Papalexis P, Garmpis N, Aravantinou-Fatorou A,
Chlapoutakis S, Diamantis E, Nikokiris C, et al: Prognostic value
of the immunohistochemistry markers CD56, TTF-1, synaptophysin,
CEA, EMA and NSE in surgically resected lung carcinoid tumors. Mol
Clin Oncol. 16:312022. View Article : Google Scholar
|
|
15
|
Papaxoinis G, Lamarca A, Quinn AM, Mansoor
W and Nonaka D: Clinical and pathologic characteristics of
pulmonary carcinoid tumors in central and peripheral locations.
Endocr Pathol. 29:259–268. 2018. View Article : Google Scholar
|
|
16
|
Beasley MB, Thunnissen FB, Brambilla E,
Hasleton P, Steele R, Hammar SP, Colby TV, Sheppard M, Shimosato Y,
Koss MN, et al: Pulmonary atypical carcinoid: Predictors of
survival in 106 cases. Hum Pathol. 31:1255–1265. 2000. View Article : Google Scholar
|
|
17
|
Halabi S and Owzar K: The importance of
identifying and validating prognostic factors in oncology. Semin
Oncol. 37:e9–e18. 2010. View Article : Google Scholar
|
|
18
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 World Health Organization
classification of lung tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar
|
|
19
|
Feng SH and Yang ST: The new 8th TNM
staging system of lung cancer and its potential imaging
interpretation pitfalls and limitations with CT image
demonstrations. Diagn Interv Radiol. 25:270–279. 2019. View Article : Google Scholar
|
|
20
|
Woodring JH and Reed JC: Types and
mechanisms of pulmonary atelectasis. J Thorac Imaging. 11:92–108.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Müller NL, Fraser RS, Colman NC and Paré
PD: Radiologic diagnosis of diseases of the chest. WB Saunders;
Philadelphia, PA: 2001
|
|
22
|
Tepavac A, Secen N, Sazdanic Velikic D,
Popovic G and Perin B: Atelectasis: Positive or negative prognostic
factor on outcome of patients with non-small cell lung cancer? J
BUON. 15:679–683. 2010.PubMed/NCBI
|
|
23
|
Gu K, Lee HY, Lee K, Choi JY, Woo SY, Sohn
I, Kim HK, Choi YS, Kim J, Zo JI and Shim YM: Integrated evaluation
of clinical, pathological and radiological prognostic factors in
squamous cell carcinoma of the lung. PLoS One. 14:e02232982019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hasbek Z, Yucel B, Salk I, Turgut B,
Erselcan T, Babacan NA and Kacan T: Potential impact of atelectasis
and primary tumor glycolysis on F-18 FDG PET/CT on survival in lung
cancer patients. Asian Pac J Cancer Prev. 15:4085–4089. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bulbul Y, Eris B, Orem A, Gulsoy A, Oztuna
F, Ozlu T and Ozsu S: Pulmonary atelectasis and survival in
advanced non-small cell lung carcinoma. Ups J Med Sci. 115:176–180.
2010. View Article : Google Scholar
|
|
26
|
Dediu M, Crisan E, Radut M, Tarlea A,
Median D, Alexandru A, Vremes G and Gal C: The favorable prognostic
significance of atelectasis in patients with advanced non-small
cell lung cancer: Results of a prospective observational study.
Lung Cancer. 63:271–276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pang Z, Ding N, Dong W, Ni Y, Zhang T, Qu
X, Du J and Liu Q: Prognostic effects of preoperative obstructive
pneumonitis or atelectasis and comparison with tumor size in
non-small cell lung cancer. J Thorac Dis. 9:768–778. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Standards for the diagnosis and care of
patients with chronic obstructive pulmonary disease, . American
thoracic society. Am J Respir Crit Care Med. 152:S77–S121.
1995.PubMed/NCBI
|
|
29
|
Liu S, Ko S and Chen W: Bronchial
carcinoid tumor presenting with complete lobar collapse and
unilateral lung emphysema. Clin Imaging. 24:159–161. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sato S, Nakamura M, Shimizu Y, Goto T,
Koike T, Ishikawa H and Tsuchida M: The impact of emphysema on
surgical outcomes of early-stage lung cancer: A retrospective
study. BMC Pulm Med. 19:732019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee SJ, Yoo JW, Ju S, Cho YJ, Kim JD, Kim
SH, Jang IS, Jeong BK, Lee GW, Jeong YY, et al: Quantitative
severity of pulmonary emphysema as a prognostic factor for
recurrence in patients with surgically resected non-small cell lung
cancer. Thorac Cancer. 10:421–427. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao YH, Guan WJ, Liu Q, Wang HQ, Zhu YN,
Chen RC and Zhang GJ: Impact of COPD and emphysema on survival of
patients with lung cancer: A meta-analysis of observational
studies. Respirology. 21:269–279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee HY, Kim EY, Kim YS, Ahn HK and Kim YK:
Prognostic significance of CT-determined emphysema in patients with
small cell lung cancer. J Thorac Dis. 10:874–881. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Georgakopoulou VE, Trakas N, Damaskos C,
Garmpis N, Karakou E, Chatzikyriakou R, Lambrou P and Tsiafaki X:
Neutrophils to lymphocyte ratio as a biomarker in bronchiectasis
exacerbation: A retrospective study. Cureus.
12:e97282020.PubMed/NCBI
|
|
35
|
Meng Z and Linian H: A typical carcinoid
tumor of the lung presenting as diffuse cystic bronchiectasis. J
Coll Physicians Surg Pak. 30:229–230. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Charokopos N, Tsiamita M, Karkoulias K,
Koumoundourou D, Aletra C, Dougenis D and Spiropoulos K: Carcinoid
tumour behind bronchiectasis. Monaldi Arch Chest Dis. 65:110–113.
2006.PubMed/NCBI
|
|
37
|
Janah H, Jabri H, Bopaka RG, Khattabi WE
and Afif H: Localised bronchiectasis revealing carcinoid tumor. Pan
Afr Med J. 24:2782016.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ghobadi H, Farzaneh E and Darvishkhah H:
Carcinoid tumor with localized bronchiectasis. Tanaffos. 12:56–60.
2013.PubMed/NCBI
|
|
39
|
Liu B, Pu Q, Liu L and Che G: Facial
flushing due to multifocal tumorlets in the lung with
bronchiectasis. Ann Thorac Surg. 88:641–642. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Klinke F, Bosse U and Höfler H: The
tumorlet carcinoid in bronchiectasis-changed lungs. An example of a
multifocal, endocrine tumor. Pneumologie. 44 (Suppl 1):S607–S609.
1990.(In German).
|
|
41
|
Canessa PA, Santini D, Zanelli M and
Capecchi V: Pulmonary tumourlets and microcarcinoids in
bronchiectasis. Monaldi Arch Chest Dis. 52:138–139. 1997.PubMed/NCBI
|
|
42
|
Chakraborty RK, Basit H and Sharma S:
Desquamative Interstitial Pneumonia. StatPearls Treasure Island
(FL): StatPearls Publishing; August 12–2020
|
|
43
|
Bischoff P, Trinks A, Wiederspahn J,
Obermayer B, Pett JP, Jurmeister P, Elsner A, Dziodzio T, Rückert
JC, Neudecker J, et al: The single-cell transcriptional landscape
of lung carcinoid tumors. Int J Cancer. 150:2058–2071. 2022.
View Article : Google Scholar : PubMed/NCBI
|
